Irma Febo to Placebos
This is a "connection" page, showing publications Irma Febo has written about Placebos.
Connection Strength
0.096
-
Romas L, Birse K, Mayer KH, Abou M, Westmacott G, Giguere R, Febo I, Cranston RD, Carballo-Di?guez A, McGowan I, Burgener A. Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression. AIDS Res Hum Retroviruses. 2016 Oct/Nov; 32(10-11):1005-1015.
Score: 0.037
-
Giguere R, Dolezal C, Bauermeister JA, Frasca T, Valladares J, Febo I, Cranston RD, Mayer K, McGowan I, Carballo-Di?guez A. Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico. J Sex Res. 2016 Jul-Aug; 53(6):633-41.
Score: 0.034
-
McGowan I, Gomez K, Bruder K, Febo I, Chen BA, Richardson BA, Husnik M, Livant E, Price C, Jacobson C. Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004). AIDS. 2011 May 15; 25(8):1057-64.
Score: 0.026